Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 24/03/2008 Photograph of a Biochip reader

    Successful cooperation between science and industry

    At the recent Science meets Business Day four tandem teams of the German BioValley Platform presented their projects. These will be introduced in two articles. The first article focuses on natural substances with a pharmaceutical potential.

    https://www.gesundheitsindustrie-bw.de/en/article/news/successful-cooperation-between-science-and-industry
  • Article - 20/03/2008

    The effect of migration from Africa on genetic diversity in Europe

    The paper by Lohmueller et al. 2008 shows that there is proportionally more deleterious genetic variation in European than in African populations. This revelation enables conclusions to be made on the group that emigrated from Africa several thousand years ago.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-effect-of-migration-from-africa-on-genetic-diversity-in-europe
  • Article - 19/03/2008

    Innovendia: Keeping the focus on client requirements

    The biotechnology sector is growing and new companies have excellent opportunities to establish themselves on the market. Dr. Michael Steinwand explains what companies have to beware.

    https://www.gesundheitsindustrie-bw.de/en/article/news/innovendia-keeping-the-focus-on-client-requirements
  • Article - 19/03/2008

    Nycomed intends to move chemical production to Indian joint venture

    Nycomed and Cadila Healthcare have signed a letter agreement with the intent to amend their existing joint venture agreement to include the chemical production of active pharmaceutical ingredients (APIs) by the joint venture company Zydus Nycomed in India. Based on this agreement, Nycomed plans to transfer the current chemical production from the sites in Linz (Austria) and Singen (Germany) to the new joint venture within the next three to four…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nycomed-intends-to-move-chemical-production-to-indian-joint-venture
  • Article - 17/03/2008

    Retinal microchip provides slight hope

    Is there a slight chance that patients suffering from Retinitis pigmentosa or even from age-related macular degeneration might be able to regain their vision? A microchip implanted beneath the retina might at least give such patients the ability to make out the outlines of objects.

    https://www.gesundheitsindustrie-bw.de/en/article/news/retinal-microchip-provides-slight-hope
  • Article - 17/03/2008

    FDA approves Vetter Pharma client drug

    Vetter Pharma Fertigung GmbH Co has been granted approval by the American Food and Drug Administration FDA for the production of a new client drug. Vetter will now be filling injection systems with the new drug at its Ravensburg facility. Vetter has invested over 100 million euros.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/fda-approves-vetter-pharma-client-drug
  • Article - 16/03/2008 Logo apogenix

    New indication for lead compound of Apogenix

    Isolated tumour cells use to invade healthy brain tissue during the development and growth of glioblastoma multiforme GBM. This mechanism involves the CD95CD95L death system. These results supports the therapeutic potential of Apogenix APG101 for the treatment of glioblastomas.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-indication-for-lead-compound-of-apogenix
  • Article - 16/03/2008

    Lego system for production plants

    Things that work on a small scale are not necessarily as successful on a large one. It takes a lot of patience and money to scale up analytical or therapeutic processes from the laboratory to industrial production. A new platform consisting of several building blocks minimises the costs.

    https://www.gesundheitsindustrie-bw.de/en/article/news/lego-system-for-production-plants
  • Article - 15/03/2008

    Zeiss continues growing

    Revenues of the Carl Zeiss Group in the 200607 tax year rose seven percent to EUR 2604 million. The Carl Zeiss Group generates approximately 83 per cent of its business outside Germany. Once again the strongest area was the semiconductor business.

    https://www.gesundheitsindustrie-bw.de/en/article/news/zeiss-continues-growing
  • Article - 15/03/2008

    Two Cluster of the Rhine-Neckar Metropolitan successful

    Of twelve applications which qualified for the decisive final round of the top cluster competion two are from the Rhine-Neckar metropolitan area the Forum Organic Electronics cluster and the Cell-Based Molecular Medicine biotechnology cluster.

    https://www.gesundheitsindustrie-bw.de/en/article/news/two-cluster-of-the-rhine-neckar-metropolitan-successful
  • Article - 15/03/2008

    Double success for research

    The Albstadt-Sigmaringen University of Applied Sciences has been successful in the states Innovative Projects Cooperative Projects 2007 programme. Two research projects will receive funding totalling almost 225000 euros.

    https://www.gesundheitsindustrie-bw.de/en/article/news/double-success-for-research
  • Article - 15/03/2008

    Mannheim as a stroke research centre

    Neurologists at the University Hospital of Mannheim are the central points of contact of the largest European stroke project to date. The European Union is providing more than 21 million euros over five years for research focusing on stroke.

    https://www.gesundheitsindustrie-bw.de/en/article/news/mannheim-as-a-stroke-research-centre
  • Press release - 15/03/2008

    Practical report: the combination of biology and process engineering

    If the environment is right and both sides are genuinely interested in working together then the cooperation between biologists and engineers will lead to top technologies. One example of such cooperations is the bioreactors of the Department of Cell Systems at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB in Stuttgart.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/practical-report-the-combination-of-biology-and-process-engineering
  • Article - 14/03/2008

    "Facility of the Year" in the city of Illertissen

    The International Society for Pharmaceutical Engineering ISPE awarded Pfizer in Illertissen municipal district of Neu Ulm the Facility of the Year Award in the process innovation category for its fully-automated production plant.

    https://www.gesundheitsindustrie-bw.de/en/article/news/facility-of-the-year-in-the-city-of-illertissen
  • Article - 14/03/2008

    Elisa Izaurralde, a prominent RNA scientist, receives Leibniz Prize

    The directors of the Tübingen Max Planck Institute MPI for Developmental Biology are pleased to have a Leibniz prizewinner in their ranks for the second year running. Dr. Elisa Izaurralde and her colleague Dr. Elena Conti have both been awarded the 2008 prize for their outstanding work in the field of RNA research.

    https://www.gesundheitsindustrie-bw.de/en/article/news/elisa-izaurralde-a-prominent-rna-scientist-receives-leibniz-prize
  • Article - 11/03/2008

    Nils Johnsson delivers initial insights

    Nils Johnssons work focuses on communication research involving living objects. The 48-year-old biochemist is investigating how proteins manage the complicated process of cytokinesis the division of the cell plasma. Thanks to a specific method Johnsson is able to detect when proteins are interacting with each other.

    https://www.gesundheitsindustrie-bw.de/en/article/news/nils-johnsson-delivers-initial-insights
  • Article - 11/03/2008

    "Medical Technology and Health cluster concept" in the second round

    The Federal Ministry of Research and Education BMBF announced that the top cluster proposal Medical Technology and Health TuttlingenNeckar-Alb MedCare TechArea has qualified for the second round of the Top Cluster competition which is part of the governments high-tech strategy.

    https://www.gesundheitsindustrie-bw.de/en/article/news/medical-technology-and-health-cluster-concept-in-the-second-round
  • Article - 10/03/2008

    Optical Technologies Research 2008

    The major focus of the planned research initiative is precompetitive and application-oriented basic and initial research.

    https://www.gesundheitsindustrie-bw.de/en/article/news/optical-technologies-research-2008
  • Article - 10/03/2008

    The latest on ubiquitin

    Christiane Pelzer and Ingrid Kassner biologists at the University of Constance recently discovered a previously unknown protein that plays a role in the binding of ubiquitin to target proteins. This discovery is a milestone in the research of basic enzymatic processes.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-latest-on-ubiquitin
  • Article - 10/03/2008

    Heinz Schaller receives Löffler Frosch Medal

    Heinz Schaller of the Centre for Molecular Biology at the University of Heidelberg ZMBH was awarded the Löffler Frosch Medal for his research on viral infections. He was co-founder of the biotechnology company Biogen.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heinz-schaller-receives-loeffler-frosch-medal
  • Article - 09/03/2008 Portrait of Dr. Anja Apel

    Successful attack on resistant tumour cells

    In laboratory experiments Dr. Anja Apel from the University Hospital in Heidelberg proved that cancer cells that are resistant to radiation therapy can be made to become susceptible to this kind of treatment again by blocking the cells own recycling system.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/successful-attack-on-resistant-tumour-cells
  • Article - 07/03/2008

    Establishment of the German Health Regions Network

    The German Health Regions Network association was instituted on the 14th February 2008. The association acknowledges the growing importance of the health care industry and hopes to strengthen it with a particular focus on the project-related cooperation between the German health regions.

    https://www.gesundheitsindustrie-bw.de/en/article/news/establishment-of-the-german-health-regions-network
  • Article - 07/03/2008

    Hans-Ulrich Kauczor - expert in diagnostic radiology

    Since the 1st March 2008 the Department of Diagnostic Radiology at the University Hospital in Heidelberg has a new medical director Professor Dr. Hans-Ulrich Kauczor 45 succeeds Professor Dr. Günter Kauffmann.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hans-ulrich-kauczor-expert-in-diagnostic-radiology
  • Press release - 06/03/2008

    Paediatrist from Ulm to receive Friedrich Linneweh Award

    Manfred Hönig paediatrist from Ulm University Childrens Hospital has received the Friedrich Linneweh Award for the promotion of young scientists in the field of paedriatrics. Hönig received the prize for his research on the development of immune cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/paediatrist-from-ulm-to-receive-friedrich-linneweh-award
  • Press release - 04/03/2008

    When success inflates costs

    Red biotechnology became commercially successful because process engineering succeeded in expressing foreign genes in microorganisms and got a grip on cells tissue cells were not only cultivated using technical methods but also purified for medical application on an industrial scale. However the biopharmaceutical industry is now facing rising costs.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/when-success-inflates-costs

Page 114 / 119

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 119
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search